Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
Global Key SolutionsGKS
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Perfection Vapes, Inc.
WARNING LETTER
•Perfection Vapes, Inc.•January 15, 2021

FDA WARNING_LETTER - Perfection Vapes, Inc. - January 15, 2021

View on Dashboard

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

ChatGPT

Claude

Perplexity

Grok

Record Details

The FDA issued a Warning Letter to Victor Canastraro of Perfection Vapes on January 15, 2021, following a review of their website, perfectionvapes.com. The FDA determined that e-liquid products offered for sale, specifically "Banana Nut Kringle" and "Krunchy Berry with Milk," are tobacco products under section 201(rr) of the FD&C Act and are subject to FDA regulation.

These e-liquid products are considered "new tobacco products" because they were not commercially marketed in the U.S. as of February 15, 2007. The FDA found that these products lack the required premarket marketing authorization order under section 910(c)(1)(A)(i) of the FD&C Act and are not otherwise exempt. Consequently, these products are deemed adulterated under section 902(6)(A) and misbranded under section 903(a)(6) of the FD&C Act, as required information under section 905(j) was not provided.

The letter emphasizes the firm's responsibility, as a registered manufacturer with over 41,500 listed products, to ensure compliance with the FD&C Act and FDA regulations (21 C.F.R. Parts 1140, 1141, and 1143). Failure to address these violations

Company
Perfection Vapes, Inc.
Inspection Date
January 15, 2021
Product Type
Tobacco
Office
Center for Tobacco Products
People
  • Ann Simoneau (Director)
  • Victor Canastraro
  • Michael S. Gawel
  • Kathleen Henderson
Open in Dashboard

ID · 26611efd-e8d3-43aa-b2d2-2debbd526d7a

Violation Codes10
21 U.S.C. 387j(a)21 CFR 114321 CFR 1100.121 U.S.C. 387a(b)21 U.S.C. 902(6)(A)21 U.S.C. 387e(j)(3)21 U.S.C. 387e(j)21 U.S.C. 387j(c)(1)(A)(i)21 U.S.C. 321(rr)21 CFR 1140

Full citation text and observation details available on the Dashboard.

footer
Global Key Solutions
Regulatory Data Transformed
Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@globalkeysolutions.net
Quick Links
KeyPedia™ Lite
Legal & Ethics
©2026, Global Key Solutions All rights reserved.